Triple negative breast cancer responded well to combination therapy
(dailyRx News) Triple-negative breast cancer is a fast-growing form of the disease that tends to return (recur). But a fresh therapeutic approach was found to be capable of eliminating the disease altogether. New research demonstrated that a combination therapy involving standard chemotherapy, Paraplatin (carboplatin) and Avastin (bevacizumab) was effective in wiping out triple-negative breast cancer before surgery.
Women whose cancer disappeared are expected to have a much lower risk of recurrence than patients whose cancer did not respond to the therapy given before surgery (neoadjuvant).
Read more from RxWiki HERE.